"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A study looking at a different type of MRI scan to help plan treatment for retroperitoneal sarcoma (PIRS)
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
Researchers wanted to see if a functional MRI scan gave more information than scans already used to plan radiotherapy or surgery to treat soft tissue sarcoma.
This study was for people with a soft tissue sarcoma behind the organs in their tummy (abdomen). Doctors call this a retroperitoneal sarcoma.
Cancer Research UK supported this study.
More about this trial
Doctors usually use CT scans when planning these treatments.
In this study, researchers want to see if a type of MRI scan called functional MRI (fMRI) gave more information. This scan shows what is happening inside the cancer, rather than simply its size and location.
They hoped that fMRI would help doctors to better assess sarcomas before surgery. And help them to see how well a tumour had responded to radiotherapy.
The main aim of this study was to see if fMRI scans helped improve treatment planning for people with retroperitoneal sarcoma.
Summary of results
How to join a clinical trial
Dr Christina Messiou
Cancer Research UK
NIHR Clinical Research Network: Cancer
National Institute for Health Research Clinical Research Facility in Imaging
The Royal Marsden NHS Foundation Trust